Business Wire

NY-PYRAMID-ANALYTICS

30.11.2022 09:01:54 CET | Business Wire | Press release

Share
Pyramid Analytics Signs More UKI Channel Deals

Pyramid Analytics (Pyramid), a pioneering decision intelligence platform provider, continues to consistently execute on its strategy to rapidly expand channel partnerships with complementary technology companies, independent software vendors (ISV), consulting firms, value-added resellers (VAR) and systems integrators (SI) across the United Kingdom and Ireland (UKI). The London-based software company today announced new partnerships with Datazed Associates, Data Reply, and Digital Data Consultancy.

Key Points:

  • Pyramid Analytics signed deals with new partners serving the IT needs of mid-size and large enterprises across the UKI: Datazed Associates (Referral Partner); Digital Data Consultancy (Systems Integrator); and Data Reply (Consultancy, Systems Integrator).
  • The channel partner programme is the backbone of Pyramid’s UKI operations, accounting for a significant segment of UK revenue.
  • Pyramid Analytics is recognized for channel excellence. The company was a CRN Channel Awards 2022 finalist.
  • To learn more about becoming a Pyramid partner in the UK and Ireland, contact Bill Clayton, Vice President, Global Partnerships, at bill.clayton@pyramidanalytics.com.

Meet Pyramid Analytics’ New Partners
Datazed Associates is a boutique data consultancy specialising in data governance and data quality. The company’s network of experienced professionals has a strong track record in the insurance industry, having supported general insurers, Lloyd’s market firms, brokers and reinsurers.

Data Reply is the Reply group company offering a broad range of advanced analytics and AI-powered data services. Data Reply operates across industries and business functions to achieve meaningful outcomes through effective use of data.

Digital Data Consultancy provides consulting services in the areas of data management, data science, and digital experience. The company helps clients in retail, hospitality, healthcare, banking and consumer goods to master and reimagine their data, create new value, and differentiate and profit in the digital economy.

Pyramid Analytics Delivers Value for Partners
Partnerships are critical to Pyramid’s ability to scale growth. In turn, partners get access to the Pyramid Decision Intelligence Platform, an innovative augmented analytics platform which has garnered analyst accolades for its ability to transform businesses.

Pyramid Partners benefit from a range of resources to help them effectively market, sell, and deliver the Pyramid Platform, integrated solutions, and services. These include the Pyramid Partner Portal, a one-stop shop for deal management, market education content, co-branded marketing materials, and interactive tools and resources; and the Pyramid Learning Hub for self-guided and expert-led courses, and Pyramid Partner Certification programs.

United Kingdom the World’s “Next Silicon Valley”?
Jeremy Hunt, the UK’s Chancellor of the Exchequer, outlined a number of priorities in his Autumn Statement on 17 November. These included his plan to “turn the United Kingdom into the world’s next Silicon Valley.” Pyramid Analytics has operated and flourished in the UK for nearly five years and are proud of the company’s contribution to achieving this goal. The advanced analytics platform company has added three executives and numerous business development roles in its London office in 2022.

2022 has been momentous for Pyramid Analytics in the UKI:

  • Pyramid executives, customers, partners, media and technology industry analysts celebrated a $120 million Series E funding round at a special event at Tower Bridge in May.
  • Tom Warren, a veteran technology professional and former professional rugby player, was appointed Managing Director for the company’s UKI operations.
  • Bill Clayton joined Pyramid in the new role of Vice President, Global Partnerships. He has more than 20 years of enterprise software experience. Clayton has held positions with global technology leaders including IBM and Oracle. He lives in the UK.
  • Hayley Munro was appointed Vice President of Global Customer Success. This newly created role provides unified, company-wide management of this critical function under one executive. She lives in the UK.

Decision Intelligence is the Next Big Data Analytics Innovation
The next major innovation in analytics is Artificial Intelligence (AI). Applying AI across Data Prep, Business Analytics, and Data Science is what separates Decision Intelligence from traditional business intelligence tools such as Microsoft Power BI, Qlik, and Tableau. AI lowers the skills barrier by automating the highly technical work needed to prepare and analyze data and create and share reports and dashboards.

The Pyramid Decision Intelligence Platform delivers data-driven insights for anyone to make faster, more intelligent decisions. The Pyramid Platform provides instant access to any data, enables automated governed self-service for any person, and serves any analytics need, from the simple to the sophisticated. By uniquely combining Data Prep, Business Analytics, and Data Science with AI guidance in a single environment, the Pyramid Platform reduces cost and complexity while accelerating growth and innovation. This enables a strategic, organization-wide approach to Business Intelligence and Analytics.

Quotes
Bill Clayton, Vice President of Global Partner Sales, Pyramid Analytics: “Channel partnerships are an essential cornerstone of Pyramid’s growth strategy. Our highly productive and effective work with channel partners has forged a host of mutually beneficial relationships that have driven growth for all involved across the UKI. Channel partners are at the core of Pyramid’s business model. The growth and expansion of the company is firmly embedded with our channel partners.”

About Pyramid Analytics
Pyramid is what’s next in analytics. The award-winning Pyramid Decision Intelligence Platform delivers insights for faster, optimized decisions by providing direct access to any data, enabling governed self-service for any person, and meeting any analytics need in a no-code environment. The Pyramid Platform uniquely combines Data Prep, Business Analytics, and Data Science in a single environment with AI guidance, reducing cost and complexity while accelerating growth and innovation. This enables a strategic, enterprise-wide approach to Business Intelligence and Analytics, from the simple to the sophisticated. Schedule a demo.

Pyramid Analytics is incorporated in Amsterdam and has regional headquarters in global innovation and business centers, including London, New York City, and Tel Aviv. Our team lives worldwide because geography should not be a barrier to talent and opportunity. Investors include H.I.G. Growth Partners, Jerusalem Venture Partners (JVP), Sequoia Capital, and Viola Growth. Learn more at Pyramid Analytics.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221130005245/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release

Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P

Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release

Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result

Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release

Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said

SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release

In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin

Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release

Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye